The Future of Drug Safety Promoting and Protecting the Health of the Public (2007) / Chapter Skim
Currently Skimming:
Appendix F Committee Biographies
Appendix F Committee Biographies
Pages 309-318
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 309... ...
Appendix F Committee Biographies COMMITTEE ON THE ASSESSMENT OF THE US DRUG SAFETY SYSTEM Sheila Burke (Chair) , MPA, RN, is deputy secretary and chief operating officer of the Smithsonian Institution.
|
From page 310... ...
0 THE FUTURE OF DRUG SAFETY tor of the Institute for Health Policy at Massachusetts General Hospital and Partners HealthCare System.
|
From page 311... ...
APPENDIX F Drug Administration law, biotechnology law, bioethics, and reproductive rights. In addition, she has served on the UW Hospital clinical-ethics committee, the UW institutional review board for the protection of human subjects in medical research, and the UW Bioethics Advisory Committee.
|
From page 312... ...
Dr. Ellenberg is a fellow of the American Statistical Association and the American Association for the Advancement of Science and an elected member of the International Statistical Institute.
|
From page 313... ...
He has been chairman of the Stanford University Committee on Research, president of the American Association of Pathologists (now the American Society for Investigative Pathology) , president of the Association of Pathology Chairmen; member of the Board of Directors and the Executive Committee of the Federation of American Societies for Experimental Biology, and member of the Board of Directors of the Association of Academic Health Centers.
|
From page 314... ...
Dr. Meltzer's research interests include the theoretical foundations of medical cost-effectiveness analysis, the effects of medical specialization and prospective payment systems on the cost and quality of care, and the effects of Food and Drug Administration regulation on innovation in the pharmaceutical industry.
|
From page 315... ...
Dr. Olson has expertise on Food and Drug Administration (FDA)
|
From page 316... ...
THE FUTURE OF DRUG SAFETY and the Women's Health Initiative. He is the chair of the NIH Cardiovascular Disease and Sleep Epidemiology Study Section and chair of the Group Health Research Committee.
|
From page 317... ...
He was the 1990 American College of Preventive Medicine/Burroughs Wellcome Scholar in Pharmacoepidemiology. The American Association of Pharmaceutical Research Scientists awarded Dr.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.